binx offers first FDA 510(k) cleared molecular point-of-care solution for test and treat of sexually-transmitted infections in a single visit
binx health present at the Canaccord Genuity Medical Technology and Diagnostics Forum - LISTEN TO THE WEBCAST HERE
binx health, the pioneer in anywhere, anytime testing for women’s health, today announced that Jeffrey Luber, president and CEO is scheduled to present on Thursday, November 21, 2019 at 11:00…
binx FDA-cleared platform already impacting human health—poised to transform care for millions
binx io enables first-ever “test-and-treat” paradigm with sample to answer in 30 minutes for the two most tested-for sexually transmitted infections (STIs)
binx health, the pioneer in anywhere care in women’s health, today announced the appointment of Dr. Gail Marcus to its Board of Directors.
Aiming to drive greater adoption of tests for sexually transmitted diseases, binx health believes it is well placed to benefit from an expansion of services at US health clinics with…
Multiplex Test Panel for binx io® Point-of-Care Platform. Positioned to Radically Reduce Time to Treatment, Expand Access to Care
binx health, a pioneer in convenient health, today announced that it has appointed Samar Parikh to its Board of Directors.
Study reports 93% sensitivity and 99% specificity in 30-minute desktop instrument